Comment on “48-Week Outcome After Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors With Relapse”

Canadian Journal of Gastroenterology and Hepatology - Egypt
doi 10.1155/2019/4927083
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Tenofovir Plus Entecavir Combination Therapy for Chronic Hepatitis B With Nucleos(t)ide Analogue Failure

The European Research Journal
2020English

Editorial: HBeAg Seroconversion Is Not Sufficient to Allow Cessation of Nucleos(t)ide Analogue Treatment in Caucasian Hepatitis B Patients

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Combination Nucleos(t)ide Analogue as Initial Treatment for Chronic Hepatitis B: Have We Put This to Rest?

Hepatology
MedicineHepatology
2013English

Treatment of HBeAg-Negative Chronic Hepatitis B Patients With Nucleos(t)ide Analogues in Burkina Faso

Open Journal of Gastroenterology
2016English

Off-Treatment Virologic Relapse and Outcomes of Re-Treatment in Chronic Hepatitis B Patients Who Achieved Complete Viral Suppression With Oral Nucleos(t)ide Analogs

BMC Infectious Diseases
Infectious Diseases
2014English

Off-Treatment Efficacy of 3-Year Nucleos(t)ide Analogues in Chronic Hepatitis B Patients

Kaohsiung Journal of Medical Sciences
Medicine
2016English

Dynamics of Hepatitis B Virus Quasispecies Heterogeneity in Association With Nucleos(t)ide Analogue Treatment Determined by MALDI-TOF MS

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2015English

Pros and Cons of Peginterferon Versus Nucleos(t)ide Analogues for Treatment of Chronic Hepatitis B

Current Hepatitis Reports
2010English

Factors Associated With Adherence to Nucleos(t)ide Analogs in Chronic Hepatitis B Patients: Results From a 1-Year Follow-Up Study

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy